Titan Pharmaceuticals's total assets for Q4 2024 were $2.92M, a decrease of -18.85% from the previous quarter. TTNP total liabilities were $483.00K for the fiscal quarter, a 30.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.